- MarketWatch•24 days ago
Shares of OraSure Technologies Inc. dropped 6.1% in premarket trade Friday, after the diagnostic device maker said it agreed to an early termination of its co-promotion agreement with AbbVie Inc. . The ...
- Capital Cube•last month
Click here to see latest analysisCapitalcube gives OraSure Technologies, Inc. a score of 81.Our analysis is based on comparing OraSure Technologies, Inc. with the following peers – Trinity Biotech Plc Sponsored ADR Class A, Alere Inc., Cooper Companies, Inc., Venaxis, Inc., Response Genetics, Inc., Quidel Corporation, Quest Diagnostics Incorporated, Vermillion, Inc., Chembio Diagnostics, Inc. and […] (Read more...) The post OraSure Technologies, Inc. – Value Analysis (NASDAQ:OSUR) : June 17, 2016 appeared first on CapitalCube.
OraSure Technologies, Inc.NasdaqGS
After hours: 6.460.00 (0.00%) as of 4:44 PM EDT
|Bid||5.60 x 500|
|Ask||8.30 x 200|
|52wk Range||4.39 - 7.99|
|Day's Range||6.37 - 6.53|
|Avg Vol (3m)||831,133|
As of 4:00 PM EDT. Market closed.